TD Waterhouse Canada Inc. Sells 166,891 Shares of CVS Health Co. (NYSE:CVS)

TD Waterhouse Canada Inc. reduced its position in CVS Health Co. (NYSE:CVS - Free Report) by 33.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 337,007 shares of the pharmacy operator's stock after selling 166,891 shares during the period. TD Waterhouse Canada Inc.'s holdings in CVS Health were worth $15,128,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of CVS. Ridgewood Investments LLC grew its stake in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after purchasing an additional 450 shares during the period. Stonebridge Financial Group LLC bought a new position in CVS Health in the fourth quarter worth approximately $28,000. Hopwood Financial Services Inc. purchased a new position in shares of CVS Health during the 4th quarter worth $29,000. Financial Perspectives Inc grew its position in shares of CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after acquiring an additional 466 shares during the period. Finally, MidAtlantic Capital Management Inc. increased its stake in shares of CVS Health by 112.1% in the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock worth $37,000 after purchasing an additional 437 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

CVS Health Stock Performance

CVS stock opened at $65.38 on Tuesday. The firm has a market cap of $82.43 billion, a price-to-earnings ratio of 17.86, a PEG ratio of 0.98 and a beta of 0.57. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $71.45. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The business's fifty day simple moving average is $66.50 and its two-hundred day simple moving average is $58.76.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Analysts predict that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.07%. The ex-dividend date of this dividend is Tuesday, April 22nd. CVS Health's payout ratio is 72.68%.

Analyst Upgrades and Downgrades

CVS has been the subject of several recent research reports. Leerink Partners raised CVS Health from a "market perform" rating to an "outperform" rating and boosted their price target for the company from $55.00 to $75.00 in a report on Thursday, February 13th. Mizuho boosted their price objective on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. StockNews.com raised CVS Health from a "sell" rating to a "hold" rating in a report on Thursday, February 13th. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Finally, JPMorgan Chase & Co. upped their target price on shares of CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 18th. Four analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, CVS Health presently has an average rating of "Moderate Buy" and a consensus target price of $71.83.

Insider Activity

In other CVS Health news, SVP James David Clark sold 7,513 shares of the stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the sale, the senior vice president now directly owns 8,394 shares of the company's stock, valued at approximately $556,941.90. This represents a 47.23 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Michael F. Mahoney bought 30,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The shares were purchased at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the transaction, the director now directly owns 39,356 shares of the company's stock, valued at $2,625,045.20. The trade was a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.22% of the company's stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.